The Patent Finder

Tranxenogen, Inc.

Also on record
Records under this name other than patents Tranxenogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Tranxenogen, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,326,679Anticancer peptide compositions
Lapsed on the fee record
Ended Feb 5, 2020 · USPTO record
Lapsed on the fee recordEnded Feb 5, 2020USPTO record
US 6,753,457Nuclear reprogramming using cytoplasmic extract
Lapsed on the fee record
Ended Jun 22, 2012 · USPTO record
Lapsed on the fee recordEnded Jun 22, 2012USPTO record
US 6,686,199Genetic manipulation of spermatogonia
Lapsed on the fee record
Ended Feb 3, 2012 · USPTO record
Lapsed on the fee recordEnded Feb 3, 2012USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited